This report is both encouraging and cautionary. The encouragement is that in at least a small group of patients, a reduction pneumonoplasty can reduce symptoms of breathlessness and dyspnea and improve lifestyle for at least several years after the operation. On the other hand, the mechanism by which this result is achieved remains somewhat mysterious. If the observations of the French group are documented by other groups, patients are made to feel better but some objective measures of pulmonary function may return toward their baseline value after initial improvement. This may mean that we do not know which of the many measurements of pulmonary function are those that correlate with improvement and should be monitored. It will be extremely important as we obtain further long-term follow-up data from other groups that we document the extent to which subjective improvement is related to objective improvement of specific measures. My own personal experience with these patients convinces me that there is a genuine benefit from reduction pneumonoplasty but to improve and refine selection criteria, and maximize operative technique and perioperative care, clarification of the effect on measurable, quantifiable variables is essential.
It also must be recognized that there is considerable benefit from the focus ofattention and supportive care, including intensive pulmonary rehabilitation, which is trained on these patients. It therefore follows that the ultimate challenge is to carry out a prospective, randomized comparison ofintensive medical care with this operative procedure. In this fashion, we will not only come to understand the long-term results of reduction pneumonoplasty but also whether these results are genuinely superior to intensive but more conservative management.
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